These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Machine learning-based prediction of invisible intraprostatic prostate cancer lesions on Yi Z; Hu S; Lin X; Zou Q; Zou M; Zhang Z; Xu L; Jiang N; Zhang Y Eur J Nucl Med Mol Imaging; 2022 Apr; 49(5):1523-1534. PubMed ID: 34845536 [TBL] [Abstract][Full Text] [Related]
9. Comparison of Schollhammer R; Robert G; Asselineau J; Yacoub M; Vimont D; Balamoutoff N; Bladou F; Bénard A; Hindié E; Gallerande HC; Morgat C J Nucl Med; 2023 Mar; 64(3):379-385. PubMed ID: 36215569 [TBL] [Abstract][Full Text] [Related]
10. Uncovering the invisible-prevalence, characteristics, and radiomics feature-based detection of visually undetectable intraprostatic tumor lesions in Zamboglou C; Bettermann AS; Gratzke C; Mix M; Ruf J; Kiefer S; Jilg CA; Benndorf M; Spohn S; Fassbender TF; Bronsert P; Chen M; Guo H; Wang F; Qiu X; Grosu AL Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1987-1997. PubMed ID: 33210239 [TBL] [Abstract][Full Text] [Related]
11. Prediction of clinically significant prostate cancer by [ Akcay K; Kibar A; Sahin OE; Demirbilek M; Beydagi G; Asa S; Aghazada F; Toklu T; Selcuk NA; Onal B; Kabasakal L Eur J Nucl Med Mol Imaging; 2024 Apr; 51(5):1467-1475. PubMed ID: 38112777 [TBL] [Abstract][Full Text] [Related]
12. Risk of metastatic disease on Yaxley JW; Raveenthiran S; Nouhaud FX; Samaratunga H; Yaxley WJ; Coughlin G; Yaxley AJ; Gianduzzo T; Kua B; McEwan L; Wong D BJU Int; 2019 Sep; 124(3):401-407. PubMed ID: 31141284 [TBL] [Abstract][Full Text] [Related]
13. Detection and localisation of primary prostate cancer using Kalapara AA; Nzenza T; Pan HYC; Ballok Z; Ramdave S; O'Sullivan R; Ryan A; Cherk M; Hofman MS; Konety BR; Lawrentschuk N; Bolton D; Murphy DG; Grummet JP; Frydenberg M BJU Int; 2020 Jul; 126(1):83-90. PubMed ID: 31260602 [TBL] [Abstract][Full Text] [Related]
14. [ Yang J; Xiao L; Zhou M; Li Y; Cai Y; Gan Y; Tang Y; Hu S Cancer Imaging; 2024 Jul; 24(1):86. PubMed ID: 38965552 [TBL] [Abstract][Full Text] [Related]
15. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
16. Can Yin H; Chen M; Qiu X; Qiu L; Gao J; Li D; Fu Y; Huang H; Guo S; Zhang Q; Ai S; Wang F; Guo H Eur J Nucl Med Mol Imaging; 2021 Oct; 48(11):3693-3701. PubMed ID: 33813594 [TBL] [Abstract][Full Text] [Related]
17. The role of [ Basso Dias A; Mirshahvalad SA; Ortega C; Perlis N; Berlin A; van der Kwast T; Ghai S; Jhaveri K; Metser U; Haider M; Avery L; Veit-Haibach P Eur J Nucl Med Mol Imaging; 2023 Jun; 50(7):2167-2176. PubMed ID: 36809425 [TBL] [Abstract][Full Text] [Related]
18. Significance of metabolic tumor volume and total lesion uptake measured using Ga-68 labelled prostate-specific membrane antigen PET/CT in primary staging of prostate cancer. Kubilay E; Akpinar Ç; Oǧuz ES; Araz MS; Soydal Ç; Baltacı S; Ürün Y; Süer E Urol Oncol; 2022 Sep; 40(9):408.e19-408.e25. PubMed ID: 35902300 [TBL] [Abstract][Full Text] [Related]
19. Dual time point imaging of staging PSMA PET/CT quantification; spread and radiomic analyses. Aksu A; Vural Topuz Ö; Yılmaz G; Çapa Kaya G; Yılmaz B Ann Nucl Med; 2022 Mar; 36(3):310-318. PubMed ID: 34988888 [TBL] [Abstract][Full Text] [Related]
20. The diagnostic accuracy of Rajwa P; Heidenreich J; Drzezga A; Schmidt M; Shariat SF; Heidenreich A Prostate; 2024 Jan; 84(1):74-78. PubMed ID: 37750292 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]